I am a Life Science Researcher with over 16 years of experience in ophthalmology, molecular vision science, and diabetic retinopathy research at the Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. My research expertise encompasses experimental animal models of retinal disease, retinal microsurgery, molecular biology, and genetically engineered knockout mouse models.
I am a member of an established research team under the supervision of Professor Ahmed M. Abu El-Asrar. Our research focus is on the molecular mechanisms driving the pathogenesis and progression of diabetic retinopathy, investigating retinal inflammation, angiogenesis, oxidative stress, neurodegeneration, extracellular matrix remodeling, chemokine biology, matrix metalloproteinases, and emerging molecular
signaling pathways associated with diabetic retinopathy. I am particularly interested in elucidating how these pathological processes drive disease progression, and in identifying therapeutic strategies that suppress inflammation, preserve blood-retinal barrier (BRB) integrity, and prevent progressive vision loss and blindness.
I am a Life Science Researcher with over 16 years of experience in ophthalmology, molecular vision science, and diabetic retinopathy research at the Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. My research expertise encompasses experimental animal models of retinal disease, retinal microsurgery, molecular biology, and genetically engineered knockout mouse models.
I am a member of an established research team under the supervision of Professor Ahmed M. Abu El-Asrar. Our research focus is on the molecular mechanisms driving the pathogenesis and progression of diabetic retinopathy, investigating retinal inflammation, angiogenesis, oxidative stress, neurodegeneration, extracellular matrix remodeling, chemokine biology, matrix metalloproteinases, and emerging molecular
signaling pathways associated with diabetic retinopathy. I am particularly interested in elucidating how these pathological processes drive disease progression, and in identifying therapeutic strategies that suppress inflammation, preserve blood-retinal barrier (BRB) integrity, and prevent progressive vision loss and blindness.